SIMTEC participates in project ClEver BALLOON. It aims at the development of a new medical device for the treatment of arterial disease, an endovascular drug coated balloon catheter (DCB). The product is expected to achieve effective local administration of everolimus, a known but innovative for this specific application drug, with the use of an innovative “ClEver” drug release system that has been patented by the project partners with two international patents. The project includes development of prototypes, in vivo, in vitro and in silico studies.
Partners of the project are the following: University of Thessaly, University of Ioannina, University of Patras, Biomedical Research Foundation of the Academy of Athens, Rontis Hellas SA, Simtec SA.
Main purpose of the project is the development and study of a novel, safe and effective drug coated balloon that will exceed current state of the art, with a potential to become a first choice therapy for specific cases of arterial disease and its complications
